These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 8603342)
1. Cytogenetic support for primary prostatic cancer in a patient presenting with a soft tissue mass in the leg. Molenaar WM; Stoepker ME; de Ruiter AJ; Hoekstra HJ; van den Berg E Cancer Genet Cytogenet; 1996 Feb; 86(2):147-9. PubMed ID: 8603342 [TBL] [Abstract][Full Text] [Related]
3. Chromosome rearrangements in a metastatic adenocarcinoma of the prostate. Gibas Z; Pontes JE; Sandberg AA Cancer Genet Cytogenet; 1985 Apr; 16(4):301-4. PubMed ID: 3978598 [TBL] [Abstract][Full Text] [Related]
4. Highly complex chromosomal aberrations in bone marrow of a patient with metastatic prostate neoplasm. Azar GM; DiPillo F; Gogineni SK; Godec CJ; Verma RS Cancer Genet Cytogenet; 1997 Dec; 99(2):116-20. PubMed ID: 9398865 [TBL] [Abstract][Full Text] [Related]
5. Chromosome changes in benign prostatic hyperplasia and their significance in the origin of prostatic carcinoma. Casalone R; Portentoso P; Granata P; Minelli E; Righi R; Meroni E; Pozzi E; Chiaravalli AM Cancer Genet Cytogenet; 1993 Jul; 68(2):126-30. PubMed ID: 7689034 [TBL] [Abstract][Full Text] [Related]
6. Double minutes in two primary adenocarcinomas of the prostate. Limon J; Lundgren R; Elfving P; Heim S; Kristoffersson U; Mandahl N; Mitelman F Cancer Genet Cytogenet; 1989 Jun; 39(2):191-4. PubMed ID: 2752372 [TBL] [Abstract][Full Text] [Related]
8. An improved technique for short-term culturing of human prostatic adenocarcinoma tissue for cytogenetic analysis. Limon J; Lundgren R; Elfving P; Heim S; Kristoffersson U; Mandahl N; Mitelman F Cancer Genet Cytogenet; 1990 Jun; 46(2):191-9. PubMed ID: 2340490 [TBL] [Abstract][Full Text] [Related]
9. Cytogenetic characterization of an established xenografted prostatic adenocarcinoma cell line (PC-82). König JJ; Hagemeijer A; Smit B; Kamst E; Romijn JC; Schröder FH Cancer Genet Cytogenet; 1988 Aug; 34(1):91-9. PubMed ID: 3395997 [TBL] [Abstract][Full Text] [Related]
10. Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: paraffin FISH vs. metaphase analysis. Micale MA; Sanford JS; Powell IJ; Sakr WA; Wolman SR Cancer Genet Cytogenet; 1993 Aug; 69(1):7-12. PubMed ID: 8374904 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours. Alers JC; Krijtenburg PJ; Hop WC; Bolle WA; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H J Pathol; 1998 Jul; 185(3):273-83. PubMed ID: 9771481 [TBL] [Abstract][Full Text] [Related]
13. Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts. Williams BJ; Jones E; Kozlowski JM; Vessella R; Brothman AR Genes Chromosomes Cancer; 1997 Apr; 18(4):299-304. PubMed ID: 9087570 [TBL] [Abstract][Full Text] [Related]
14. Cytogenetic analysis of four primary prostatic cultures. Brothman AR; Lesho LJ; Somers KD; Schellhammer PF; Ladaga LE; Merchant DJ Cancer Genet Cytogenet; 1989 Feb; 37(2):241-8. PubMed ID: 2467737 [TBL] [Abstract][Full Text] [Related]
15. Cytogenetic aberrations in soft tissue tumors harvested from fresh tissue submitted for surgical pathology: a single institutional experience. Matthews A; Tang M; Cooper K Int J Surg Pathol; 2010 Aug; 18(4):260-7. PubMed ID: 19776087 [TBL] [Abstract][Full Text] [Related]
16. Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an adenocarcinoma of the prostate. Lundgren R; Kristoffersson U; Heim S; Mandahl N; Mitelman F Cancer Genet Cytogenet; 1988 Oct; 35(1):103-8. PubMed ID: 3180000 [TBL] [Abstract][Full Text] [Related]
17. Chromosome abnormalities are associated with unfavorable outcome in prostatic cancer patients. Lundgren R; Heim S; Mandahl N; Anderson H; Mitelman F J Urol; 1992 Mar; 147(3 Pt 2):784-8. PubMed ID: 1538480 [TBL] [Abstract][Full Text] [Related]
18. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis. Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R Urology; 1996 Feb; 47(2):218-24. PubMed ID: 8607238 [TBL] [Abstract][Full Text] [Related]
19. Chromosome 16 in primary prostate cancer: a microsatellite analysis. Osman I; Scher H; Dalbagni G; Reuter V; Zhang ZF; Cordon-Cardo C Int J Cancer; 1997 May; 71(4):580-4. PubMed ID: 9178811 [TBL] [Abstract][Full Text] [Related]
20. Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group. Mertens F; Strömberg U; Mandahl N; Dal Cin P; De Wever I; Fletcher CD; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van Den Berghe H; Vanni R; Willén H Cancer Res; 2002 Jul; 62(14):3980-4. PubMed ID: 12124330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]